Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Experimental and Molecular Therapeutics 44: Novel Drug Resistance Model Systems

Transcription of WTH3, a member of the Rab6 gene family, is suppressed in the multidrug resistant breast cancer cell line, MCF7/AdrR

Vladimir Jurukovski, Kegui Tian and Hao-Peng Xu-Duffy
Vladimir Jurukovski
SUNY at Stony Brook, Stony Brook, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kegui Tian
SUNY at Stony Brook, Stony Brook, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hao-Peng Xu-Duffy
SUNY at Stony Brook, Stony Brook, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published May 2005
  • Article
  • Info & Metrics
Loading
Proc Amer Assoc Cancer Res, Volume 46, 2005

Abstract

5090

The WTH3 gene was discovered by employing the Methylation Sensitive-Representational Difference Analysis (MS-RDA) technique to study DNA hypermethylation events in the drug sensitive cell line, MCF7/WT, as compared to its drug resistant counterpart, MCF7/AdrR. Similar to Rab6 and Rab6c, WTH3 binds to GTP. However, differing from those homologs that reside in the Golgi network, WTH3 is located mainly in the cytoplasm. Characterization of the WTH3 gene showed that its expression was down regulated in MCF7/AdrR and MES-SA/Dx5 (a human MDR uterine sarcoma cell line). Introducing the WTH3 gene into MDR cell lines reversed the MDR phenotype to various anti-cancer drugs. These results indicated that WTH3 could play an important role in MDR development. To understand the mechanisms that led to differential expression of WTH3 in MCF7/WT and MCF7/AdrR cell lines, its promoter region was analyzed. The PCR amplified promoter was cloned into the pGL3 luciferase reporter vector and its activity in MDR and non-MDR cell lines were measured. Analyses of the full length promoter showed 5 fold reduction of luciferase expression in the MCF7/AdrR cell line compared to the parental MCF7/WT, mimicking the in vivo expression of WTH3. Also, based on PATCH analysis for transcription protein binding sites, two deletion mutants of the wild type promoter were generated. One deletion was generated in a 28 bps repeat (RR28), while the other one was in the RRSp1 region (RR28 plus an adjacent Sp1 motif). omotll lenght The luciferase assays showed that both deleted sequences exerted a positive influence on the promoter’s function. Furthermore, these two cis-elements were subject to gel shift assays where MCF7/AdrR and MCF7/WT nuclear extracts were used. The results showed that different binding patterns with diverse quantities were created by the two extracts. It thus seemed that the drug treatment changed the transcriptional factors, in quantity and quality that drive the expression of WTH3 gene in MCF7/AdrR cells. Investigation of the possible characteristics of those DNA binding proteins is currently under way. Clearly, identification of those regulators could help us understand the role played by the WTH3 gene in MDR development, which may, in turn, provide future treatments of MDR in breast cancer.

  • American Association for Cancer Research
Previous
Back to top
Cancer Research: 65 (9 Supplement)
May 2005
Volume 65, Issue 9 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Transcription of WTH3, a member of the Rab6 gene family, is suppressed in the multidrug resistant breast cancer cell line, MCF7/AdrR
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Transcription of WTH3, a member of the Rab6 gene family, is suppressed in the multidrug resistant breast cancer cell line, MCF7/AdrR
Vladimir Jurukovski, Kegui Tian and Hao-Peng Xu-Duffy
Cancer Res May 1 2005 (65) (9 Supplement) 1202;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Transcription of WTH3, a member of the Rab6 gene family, is suppressed in the multidrug resistant breast cancer cell line, MCF7/AdrR
Vladimir Jurukovski, Kegui Tian and Hao-Peng Xu-Duffy
Cancer Res May 1 2005 (65) (9 Supplement) 1202;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Inhibition of IL-6 and IL-8 enhances chemosensitization in multidrug resistant human breast cancer cells
  • Inhibition of Fatty Acid Synthase (FAS) activity reverses tamoxifen resistance in Her-2/neu-overexpressing breast cancer cells
  • Two-dimensional chemotherapy simulations demonstrate fundamental transport and tumor response limitations involving nanoparticles
Show more Experimental and Molecular Therapeutics 44: Novel Drug Resistance Model Systems
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement